Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Gilead Sciences, Inc.(GILD) | 0 | 289,312 | +289,312 | $0 | $35.51M | 6.28% | +$35.51M |
| Bristol-Myers Squibb Company(BMY) | 0 | 647,899 | +647,899 | $0 | $34.95M | 6.18% | +$34.95M |
| Boston Scientific Corporation(BSX) | 262,972 | 360,428 | +97,456 | $25.67M | $34.37M | 6.07% | +$8.69M |
| BridgeBio Pharma, Inc.(BBIO) | 622,729 | 410,700 | -212,029 | $32.34M | $31.41M | 5.55% | -$930.1K |
| Eli Lilly and Company(LLY) | 57,376 | 25,923 | -31,453 | $43.78M | $27.86M | 4.92% | -$15.92M |
| Dianthus Therapeutics, Inc.(DNTH) | 667,615 | 653,572 | -14,043 | $26.27M | $26.93M | 4.76% | +$663.1K |
| Ascendis Pharma A/SADR(ASND) | 144,954 | 119,265 | -25,689 | $28.82M | $25.43M | 4.49% | -$3.39M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,614,717 | 1,196,807 | -417,910 | $24.84M | $25.14M | 4.44% | +$302.5K |
| Johnson & Johnson(JNJ) | 0 | 120,840 | +120,840 | $0 | $25.01M | 4.42% | +$25.01M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 35,344 | 29,797 | -5,547 | $19.87M | $23.00M | 4.07% | +$3.13M |
| Structure Therapeutics IncADS | 651,810 | 252,901 | -398,909 | $18.25M | $17.59M | 3.11% | -$661.4K |
| Soleno Therapeutics Inc | 418,245 | 360,340 | -57,905 | $28.27M | $16.68M | 2.95% | -$11.59M |
| Cytokinetics, Incorporated(CYTK) | 451,581 | 258,381 | -193,200 | $24.82M | $16.42M | 2.90% | -$8.40M |
| Edwards Lifesciences Corp | 0 | 187,048 | +187,048 | $0 | $15.95M | 2.82% | +$15.95M |
| Intuitive Surgical, Inc.(ISRG) | 71,343 | 27,209 | -44,134 | $31.91M | $15.41M | 2.72% | -$16.50M |
| Natera, Inc.(NTRA) | 148,369 | 62,273 | -86,096 | $23.88M | $14.27M | 2.52% | -$9.62M |
| Adaptive Biotechnologies Corporation(ADPT) | 884,890 | 821,195 | -63,695 | $13.24M | $13.34M | 2.36% | +$98.3K |
| ABIVAX Société AnonymeADS(ABVX) | 162,141 | 98,514 | -63,627 | $13.77M | $13.29M | 2.35% | -$480.7K |
| Supernus Pharmaceuticals, Inc.(SUPN) | 287,090 | 257,465 | -29,625 | $13.72M | $12.80M | 2.26% | -$924.0K |
| Fractyl Health, Inc.(GUTS) | 5,214,236 | 5,491,866 | +277,630 | $8.29M | $12.08M | 2.14% | +$3.79M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 331,849 | +331,849 | $0 | $12.04M | 2.13% | +$12.04M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,128,521 | 698,996 | -429,525 | $13.28M | $11.60M | 2.05% | -$1.69M |
| Adma Biologics Inc | 684,508 | 564,461 | -120,047 | $10.03M | $10.30M | 1.82% | +$260.9K |
| Arcellx Inc COMMON STOCK | 0 | 156,109 | +156,109 | $0 | $10.18M | 1.80% | +$10.18M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 519,715 | +519,715 | $0 | $10.17M | 1.80% | +$10.17M |
| Disc Medicine, Inc.(IRON) | 216,527 | 110,427 | -106,100 | $14.31M | $8.77M | 1.55% | -$5.54M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 714,501 | +714,501 | $0 | $8.67M | 1.53% | +$8.67M |
| Septerna, Inc.(SEPN) | 294,360 | 294,360 | 0 | $5.54M | $8.21M | 1.45% | +$2.67M |
| Protara Therapeutics, Inc.(TARA) | 1,500,793 | 1,446,254 | -54,539 | $6.53M | $7.71M | 1.36% | +$1.18M |
| uniQure N.V.SHS(QURE) | 282,940 | 288,345 | +5,405 | $16.52M | $6.90M | 1.22% | -$9.62M |
| Olema Pharmaceuticals, Inc.(OLMA) | 0 | 267,058 | +267,058 | $0 | $6.68M | 1.18% | +$6.68M |
| Terns Pharmaceuticals Inc | 0 | 136,958 | +136,958 | $0 | $5.53M | 0.98% | +$5.53M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 291,262 | 162,550 | -128,712 | $8.76M | $3.74M | 0.66% | -$5.02M |
| Heartflow, Inc.(HTFL) | 0 | 113,857 | +113,857 | $0 | $3.32M | 0.59% | +$3.32M |
| GRAIL, Inc.(GRAL) | 137,928 | 30,313 | -107,615 | $8.16M | $2.59M | 0.46% | -$5.56M |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 201,301 | +201,301 | $0 | $2.28M | 0.40% | +$2.28M |
| Billiontoone IncCL A | 0 | 25,505 | +25,505 | $0 | $2.09M | 0.37% | +$2.09M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 1,061,132 | 1,259,820 | +198,688 | $2.75M | $1.90M | 0.34% | -$846.0K |
| Hyperfine, Inc.CL A(HYPR) | 684,541 | 1,320,041 | +635,500 | $992.6K | $1.29M | 0.23% | +$300.1K |
| Palvella Therapeutics, Inc.(PVLA) | 12,010 | 10,452 | -1,558 | $752.9K | $1.09M | 0.19% | +$341.1K |
| Karyopharm Therapeutics Inc.(KPTI) | 142,984 | 142,984 | 0 | $935.1K | $1.05M | 0.19% | +$117.2K |
| Metagenomi Therapeutics, Inc.(MGX) | 528,993 | 528,993 | 0 | $1.25M | $857.0K | 0.15% | -$396.7K |
| Atai Beckley NvSHS | 196,858 | 196,858 | 0 | $1.04M | $805.1K | 0.14% | -$236.2K |
| Outset Medical, Inc.(OM) | 118,279 | 118,279 | 0 | $1.67M | $438.8K | 0.08% | -$1.23M |
| Faeth Therapeutics, Inc.(FTH) | 14,718 | 14,718 | 0 | $139.1K | $157.0K | 0.03% | +$18.0K |
| AbbVie Inc.(ABBV) | 154,834 | 0 | -154,834 | $35.85M | $0 | — | -$35.85M |
| Avidity Biosciences Inc | 263,256 | 0 | -263,256 | $11.47M | $0 | — | -$11.47M |
| Cidara Therapeutics Inc | 53,333 | 0 | -53,333 | $5.11M | $0 | — | -$5.11M |
| Endeavour Silver Corp.(EXK) | 248,987 | 0 | -248,987 | $13.62M | $0 | — | -$13.62M |
| Kyverna Therapeutics, Inc.(KYTX) | 586,909 | 0 | -586,909 | $3.52M | $0 | — | -$3.52M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 133,131 | 0 | -133,131 | $954.5K | $0 | — | -$954.5K |